Clinical Trial Update: A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of multiple doses of isavuconazole on the pharmacokinetics of repaglinide and caffeine in healthy subjects; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Caffeine (caffeine)
• Cresemba (isavuconazole)
• Prandin (repaglinide)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Pharmacokinetics of Repaglinide, Pharmacokinetics of Caffeine | Phase 1 | Status: COMPLETED